Glabellar Neurotoxin Study

We are currently enrolling for a clinical research study evaluating whether a single administration of an investigational drug called IPN10200 can help improve the appearance of frown lines in adults and whether it provides a long-lasting effect.

You may qualify to participate in this voluntary research study if you:

• Are a healthy female or male, 18 years of age or older
• Have medium to heavy frown lines
• Are unhappy with your frown lines
• Have not had any botulinum toxin treatment in any area of the body within the past 9 months
• Have not had any resurfacing procedures of the upper face within the past 12 months or other laser or microneedling treatments within the past 3 months.

Your participation in the study could last up to 12 months and consist of up to 20 office visits and 1 phone call. You will receive investigational study medication INP10200 or placebo, and study-related follow-up at no cost and compensation for time and travel may be available. The study will be conducted at the Westlake location of Westlake Dermatology (8825 Bee Caves Rd, Austin, TX) by Dr. Daniel Friedmann, a board-certified dermatologist.

To see if you qualify for this study, please email [email protected]